• By ICR Secretariat
  • Posted Wednesday, June 26, 2019

A vision for medical affairs in 2025


As innovation transforms the healthcare landscape, science and data are becoming the foundation for pharma to meet its obligations to patients and customers—and realize commercial opportunities. This imperative is accelerating the evolution of medical affairs as the third strategic pillar of the organization alongside R&D and commercial.